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with mild upper limb impairments, 6Y8 treatment methods that are appropriate for children with more severe motor impairments are needed.
The success of adult studies of robot-assisted therapy suggests that this approach may be well suited to the needs of children with moderate to severe hemiplegia. Rehabilitation robots can provide controlled, intensive task-specific training that is goal directed and cognitively engaging. Children with substantial limitations in upper or lower limb function may benefit from the graded assistance afforded by these devices to ensure a given level of success and positive engagement. Motivation during robot-assisted therapy may be greater for children because they are often both familiar with and interested in technology and computer games. In addition, it is expected that the kinematic and kinetic measures derived from robot data will contribute to the understanding of how different treatment variables (e.g., dosage, amount, and type of assistance provided) influence motor learning and recovery in children and adults. Initial studies with children presenting with moderate to severe upper limb hemiplegia due to CP or acquired brain injury 9Y12 have shown that robot-assisted therapy is well tolerated and motivating to young research participants.
UPPER LIMB STUDIES
The first studies of robot-assisted therapy for children with upper limb hemiplegia have used the InMotion2 robot (Interactive Motion Technologies, Watertown, MA), a commercial version of the MIT-Manus. This end-effector robot is easily adapted for use by children because the hand is attached at a single point of contact at the end of the robot manipulandum and specific fitting based on arm length is not required. Its therapy programs are suitable for use by children in that they are easy to understand and follow and readily adapted with child-appropriate targets and sounds (Fig. 1 ).
The first feasibility study 9 was published in 2008, in which proof of concept was established. Twelve children between the ages of 5 and 12 yrs who presented with moderate to severe motor impairments due to CP or acquired brain injury participated in 1-hr robotic therapy sessions, two times a week for 8 wks. This frequency and duration were similar to conventional rehabilitation programs for children with hemiplegia and comparable with adult stroke protocols with the InMotion2 robot. Children were excluded if they had received botulinum toxin or phenol injections within 4 mos of study enrollment or were scheduled for such a procedure during their participation in the study.
During each session, children used the paretic arm to perform 640 repetitive, goal-directed planar reaching movements with robot assist as needed, based on the child's motor abilities. These reaches involved moving to and from a central target and eight peripheral compass-point targets and were accomplished primarily via movement at the shoulder and elbow joints. If the child was unable to maintain active grasp of the robot handle, the least restrictive assist (either a grasping mitt or foam strapping) was provided to secure the hand comfortably. Computer-generated images provided visual feedback as the child attempted to actively grasp and move the robot handle to randomly presented targets. Feedback of performance was derived from robot data and provided after each set of 80 repetitions. Although the focus of robotic therapy and majority of time was spent in the robot-assisted reaching task described above, the child could choose from a number of nonpowered robotic games for Bfree play[ when time allowed during the 1-hr sessions. The random target presentation and choice of free play increased subject motivation and engagement in therapy. A single pediatric physical therapist who was blinded to previous test scores administered all baseline and outcome evaluations. 9 At the end of therapy, statistically significant improvements in upper limb coordination and quality of movement were found on the two primary outcome measures, the Quality of Upper Extremity Skills Test (P = 0.001) and the Fugl-Meyer Assessment (FMA) ( P G 0.0005). Significant gains with large effect sizes were also found for two of the Quality of Upper Extremity Skills Test subscores: dissociated movements (P G 0.0005, r = 0.53) and weight bearing (P G 0.0005, r = 0.51). These gains were ecologically meaningful, in that the parent questionnaire showed significant improvements in Bhow much[ and Bhow well[ children used the paretic arm during daily functional tasks at home. These results indicated that robotic therapy had a smaller impact on secondary measures of muscle spasticity and strength, as compared with the quality of arm coordination and motor function. 9 A similar protocol with the InMotion2 robot was administered to 12 other children with congenital or acquired brain damage attributed to stroke, traumatic brain injury, and CP. 12 Children aged 5Y15 yrs who were not engaged in conventional therapy participated in robot-assisted therapy similar to that described above. Primary differences were that sessions were held three times a week over 6 wks, fewer movement repetitions were performed at each session (384 vs. 640 in Fasoli et al. 9 ), and a handholder was used to attach the child's hand to the robot's end-effector, decreasing the need for active grasp. In addition, the children did not engage in free play games if time allowed during treatment sessions. Outcome measures were the FMA and the Melbourne Assessment of Upper Limb Function. In addition, kinematic measures were derived from robot data to assess changes in average speed and movement smoothness, as measured by a jerk metric. 13 As in the feasibility study reported above, Frascarelli et al. 12 found statistically significant changes in motor performance from admission to discharge, with moderate to large effect sizes on the Melbourne Assessment (P = 0.002) and FMA (P = 0.002). Improvements on these clinical measures were accompanied by statistically significant improvements in the jerk metric, further supporting that reaching movements with the paretic shoulder and elbow became smoother and better coordinated. The authors proposed that jerk may quantify changes in motor coordination by characterizing movement quality and recovery of interjoint coordination. 12 The first randomized control trial of robotassisted upper limb therapy in pediatrics is being performed at Blythedale Children's Hospital using the InMotion2 robot (Interactive Motion Technologies). The aim of this research is to study whether active participation in robot-assisted reaching therapy is more effective than passive movement therapy in promoting upper limb motor learning and control. To date, this study has included 22 children aged 5 to 18 yrs (11 male and 11 female children with an average age of 9.7 yrs). Criteria for inclusion were hemiparetic upper limb spasticity due to acquired brain injury at least 6 mos before enrollment in the study and the ability to play a simple video game. The average time since injury was 6.6 yrs (ranging from 0.5 to 15 yrs).
Each child had a baseline evaluation consisting of a brief medical history, vision screening to assess oculomotor status, and several tests of tone, mobility, and functional skills. Measures included the Modified Ashworth Scale to assess tone, the upper limb portion of the FMA, and the Shriner's Hospital for Children Upper Extremity Evaluation, as well as robot-mediated kinematic measurements. Children were randomly assigned to either the active or passive therapy group. Evaluations before therapy showed no significant differences between the two groups in age at injury, age at the start of robotassisted therapy, or total FMA score.
Children in the active therapy group were trained using a protocol similar to that of the studies described above, 9, 12 but with 960 repetitive movements during each therapy session. For each movement, the child attempted to actively move the robot's handle so that the cursor moved either to or from a central target and eight peripheral compass-point targets that were presented sequentially. Here again, robot assist was given if the child did not initiate or complete the movement on his/her own, with the amount of assistance provided based upon the child's performance. Feedback derived from robot data was given after each 80 movements.
Children in the passive group also performed 960 repetitive planar reaching movements. However, instead of the child attempting to move the robot's handle and the robot assisting as needed, the robot moved the handle, passively moving the child's hand while he/she watched a video of choice. These children were instructed to let the robot move their arm while they watched the video. The child's arm was not obstructed from view. Participants in both groups continued ongoing therapies (conventional occupational and physical therapy) in addition to the clinical trial but were asked not to begin new therapies during the study period. Therapy began within 2 wks of preevaluation and occurred twice a week until 16 sessions were completed.
Posttherapy evaluations occurred within 2 wks of the last therapy session. Two trained occupational therapists performed pretherapy and posttherapy evaluations and remained blinded to the experimental condition. For 19 of the 22 children, both pretherapy and posttherapy evaluations were performed by the same evaluator. Completion of a test task on the robot that was similar to the training task was significantly faster for all children (P G 0.02), with those in the active group making significantly greater gains (P = 0.03). Accuracy as measured by deviations from straight line movement improved only for children in the active group. Children in the active group showed a significantly greater decrease in tone, as measured by the Modified Ashworth Scale (P = 0.001), and a significant increase in muscle strength (P = 0.007) of the paretic arm as compared with the passive group. Both the FMA and the grasp and release measure of the Shriner's Hospital for Children Upper Extremity Evaluation showed a trend toward improvement in the active group (P G 0.08).
The initial results from this randomized control study of robotic therapy in children with chronic hemiparesis showed improvements in tone and, more importantly, in motor function as measured by the FMA. The importance of active participation in upper limb therapy was supported, and this study is ongoing. Findings suggest that robot-assisted therapy may lead to functional improvements beyond what is gained with traditional therapy and that active participation (vs. passive) led to superior results. Therapists may be able to use these gains to increase patients' activities of daily living. In addition, robot-assisted therapy provides a paradigm by which variables underlying recovery of function (e.g., intensity, duration) can be accurately controlled and studied.
To date, a limitation of pediatric upper limb robot-assisted therapy has been its primary focus on planar reaching movements of the paretic shoulder and elbow. Early iterations of rehabilitation robots that provide training for distal move-ments of the forearm, wrist, and hand are now being tested with pediatric patients. Future studies will investigate whether the training of arm and hand movements will be more effective in improving the child's functional use of the paretic arm during meaningful activities.
LOWER LIMB STUDIES
A number of researchers have studied the effects of robot-assisted gait training in children with central gait disorders related to CP and acquired brain injury. Most of this work has used a driven gait orthosis, the Lokomat (Hocoma AG, Switzerland) ( Fig. 2) or the Gait Trainer GT I (Reha-Stim, Germany), in conjunction with body weightY supported locomotor training. The aim of this intervention is to assist the child in achieving and maintaining a physiologic walking pattern for longer periods than is feasible during a conventional physical therapy session. Typical lower limb impairments related to CP include weakness and poor motor control, high agonist-antagonist coactivation, increased muscle tone, and tendon tightness at the ankle and hip. These impairments contribute to abnormal gait and high energy requirements during ambulation. 14 The use of robotic technology for lower limb rehabilitation allows for guided, task-specific training of walking that is less labor intensive than conventional therapist-aided approaches. Measurement capabilities of the robot provide quantitative data regarding the amount of therapy provided.
Several nonrandomized studies have suggested that the Lokomat is effective in improving standing and walking in children with bilateral spastic diplegia 14, 15 and tetraplegia. 16 Children with mild to severe motor impairments, scoring at levels II through IV on the Gross Motor Function Classification System (GMFCS), participated in these studies. Exclusion criteria included treatment with botulinum toxin or surgery within 3 mos of study onset; severe lower limb contractures, fractures, or contraindications of full body weight on the lower limbs; cardiovascular instability; and acute or progressive neurologic disorders. Dosage of training differed across studies, making comparisons difficult. Primary outcome measures were subscales of the Gross Motor Function Measure (GMFM), gait speed, and endurance.
Borggraefe et al. 15 examined the effects of body weightYsupported treadmill training with the Lokomat in 20 children (mean [SD] age, 11.0 [5.1] yrs) with bilateral spastic CP. Children received twelve 50-min sessions of robot-assisted treadmill training, with treatment dosage clearly tracked during the 3-wk trial. The levels of walking speed and of body weight support were progressively graded over therapy sessions to optimize gait demands. When therapist encouragement was not sufficient to motivate the child to take active steps on his own, he/she was allowed to watch a favorite cartoon during training. Mean duration per therapy session was 38.2 mins, and the mean total time walked per patient was 448 mins over the study trial. Significant gains were found on dimensions D (standing) and E (walking, running, and jumping) of the GMFM for children with mild (GMFCS I and II) and moderate to severe (GMFCS III and IV) lower limb impairment. Interestingly, children in the mild impairment group had significantly greater improvement in walking (dimension E, P = 0.005), whereas both groups showed similar gains in dimension D. The authors reported a positive correlation between gains in GMFM dimension E and the distance and time walked during intervention, suggesting a dose-dependent effect on walking abilities. 15 In this study, active participation was not monitored during Lokomat training, so the amount of active gait initiation by participants (while watching cartoons) is unclear. Because the Lokomat does not react if the child's participation decreases during treatment, 16 future studies should more closely examine the degree to which the child's active participation contributes to motor learning during training.
Borggraefe et al. 17 further examined whether motor functions achieved after 3 wks of Lokomat training were sustained at a 6-mo follow-up assessment in a separate nonrandomized study. Fourteen children with central gait disorders related to bilateral spastic CP (n = 13) and spinal paralysis (n = 1) received twelve 50-min sessions of robot-assisted treadmill training over a 3 wk period as described above. At the end of the 3-wk intervention, mean scores on the GMFM improved significantly for dimensions D (standing) and E (walking, running, and jumping). Walking endurance, measured as the distance walked during 6 mins, and gait speed also significantly improved. At the 6-mo follow-up, patients retained and extended these gains beyond that predicted by developmental curves established for children with CP. Borggraefe et al. 17 attributed this sustained effect to the Lokomat training. However, children were allowed to continue conventional therapy one to two times a week during the follow-up period, with some also receiving two to three sessions a month of robot-assisted treadmill training during this time. Without a control group, sustained outcomes cannot be confidently attributed to the 3-wk trial of body weight support treadmill training with the Lokomat.
A recent randomized control trial with 18 ambulatory children with diplegic or tetraplegic CP tested whether repetitive locomotor training with the Gait Trainer GT I could significantly improve walking speed and endurance. 18 Children in the experimental group received 30 mins of robotassisted, body weightYsupported training with the-mobilization and stretching exercises during each treatment session. The control group received 40-min sessions of conventional physical therapy focused on passive stretching, strengthening, and gait-related exercises. Participants in each group were seen for 10 treatment sessions over a 2-wk period. Primary outcomes included the 10-m walk test (walking speed) and the 6-min walk test (walking endurance). Secondary measures included the WeeFIM disability scale and three-dimensional gait analysis. No group differences were found for any of the outcome measures at baseline. Children who received robot-assisted locomotor training with the Gait Trainer GT I showed significant improvements in the primary outcome assessments as well as kinematic measures of hip joint angles, gait speed, and step length. These were retained at the 1-mo follow-up. Conversely, no significant gains were found for the control group on any performance measure. In addition, significant changes were not seen on WeeFIM scores in either treatment group, indicating that activities of daily living were not impacted by these brief locomotor interventions. 18
MOVING BEYOND ROBOT-ASSISTED THERAPY: INCORPORATING AUGMENTED OR VIRTUAL REALITY TASKS
While upper limb robot-assisted therapy has always been visually evoked and guided via a series of video games, recent studies have explored ways to further optimize children's attention and motivation. A number of investigators have begun to examine the hypothesis that robotic therapy combined with augmented or virtual reality (VR) tasks will lead to greater improvement than either therapy alone. 14,19Y22 The external focus on the effects of one's movements has been found to elicit superior skill acquisition and motor control when compared with internally focused instructions directed toward the movement itself. 23Y25 The addition of augmented or virtual tasks during training can increase the external focus and cognitive demand of robot-assisted therapies beyond the relatively simple gaming presently used during upper limb robot-assisted therapy. The augmented or virtual reaching or walking tasks may contribute to greater ecologic relevance to real-world activities, whereas the robot assist ensures a given level of success and concrete feedback about motor performance. This line of research seeks to identify further which therapeutic ingredients are essential for eliciting sustained improvement in motor con-trol and function and optimizing motivation and participation during therapy.
A number of studies have supported the use of VR interactive computer games for individuals after stroke and for children with CP, 26, 27 suggesting that the massed practice and motivational features of VR games can contribute to improved motor control in the paretic arm. However, successful engagement with commercially available VR systems is often difficult for children with CP because they lack the coordination and manipulative ability needed to interact with simulated tasks. The potential benefit of augmented VR robot-training tasks, as compared with Bserious games[ [when entertainment is not the primary goal of gaming, it is referred to as serious games] used during contemporary robot-assisted upper limb therapy, has not been well studied to date. 28 Fluet et al. 19 completed several small pilot studies that combined use of the Haptic Master robot with virtual tasks to provide opportunities for supported upper limb therapy during a number of complex simulated tasks. Virtual training tasks included reaching for cups on a shelf, catching falling objects, and driving a race car along a virtual race track. Nine children (mean age, 9 yrs) participated in three pilot studies for 1 hr per day, 3 days a week for 3 wks. One group of participants performed 5Y6 hrs of constraint-induced movement therapy in addition to this robot-assisted VR training. Overall, participants showed significant improvements on the Melbourne Assessment of Unilateral Upper Limb Function and improved reaching kinematics in terms of movement smoothness and directness of reach (path length). 19 Therapy was well tolerated by the children, and further investigations of this combined treatment are underway.
Studies of robot-assisted VR training during lower limb pediatric therapy with the Lokomat have examined the use of a virtual soccer game 20 and augmented feedback while Bwalking[ through a virtual environment. 14 In a single session, Brutsch et al. 20 examined the motor output of ten children with neurologic gait disorders and eight typically developing children. They hypothesized that immediate motor output of all participants would be significantly higher during supportive treatment conditions with VR compared with conditions without VR as a motivational factor. Active motor output in neurologically challenged and typical children was significantly higher during supported conditions (i.e., with verbal encouragement by a physical therapist, VR soccer scenario, or the combination of both) as compared with Lokomat walking without any motivational assistance. 20 VR had the same immediate effect on motor output as therapist instructions in subjects with neurologic gait disorders.
A small study of four children with CP (two classified as GMFCS level II and two classified as GMFCS level III) compared the effects of standard Lokomat training with those of augmented feedback while Bwalking[ through a VR environment. The virtual task was to collect as many coins as possible while maneuvering around obstacles; however, the virtual display was not optimized to match desired biomechanics during the gait cycle. 14 Children participated in a 6-wk Lokomat training program that involved three 30-min sessions a week. One child in each group received augmented feedback training. These preliminary results suggest that children with mild lower limb impairments (GMFCS level II) showed large changes in walking (dimension E) scores, whereas more impaired children (GMFCS level III) had a greater improvement in dimension D (standing), possibly because of improved trunk control. Notably, the two children who received gait training with augmented feedback experienced greater improvements in GMFM dimension E (walking), walking speed, and endurance compared with the standard Lokomat group,regardless of initial level impairment. 14 These gains were retained at the 3-mo follow-up.
Cioi et al. 29 and Krebs et al. 22 have taken another approach to locomotor therapy by developing devices to train ankle control of children with CP at Rutgers and Massachusetts Institute of Technology, respectively. These tools represent the pediatric embodiment of these researchers' adult devices for children aged 6 to 9 yrs. Cioi and colleagues 29 examined changes in a single 7-yr-old child who was trained with the Rutgers Ankle for a 12-wk period, three times per week. Outcome measures included dimension E (walking, running, and jumping domain) of the GMFM and kinematic gait analysis. The child practiced ankle movements in a seated position to control augmented or virtual tasks, including piloting an airplane. Improvements were found in strength and motor control, with scores on the GMFM dimension E improving from 94.4% to 98.6% from admission to discharge. Gait function also improved substantially in ankle kinematics, endurance, and self-selected walking speed, which improved from 0.98 to 1.20 m/sec. These results replicated observations in adults with stroke. 30, 31 The training of ankle control in a seated position appeared to have a significant impact on walking speed, even though the task had little resemblance to actual gait. Although these preliminary results are promising, much work is needed to further examine the effectiveness of this approach in children with CP.
As seen here, current evidence for the use of VR tasks during robot-assisted training is in its infancy. Larger controlled studies will better delineate the relative contribution and importance of robotassisted therapies with and without augmented or virtual tasks and environments. As a result, the understanding of which therapeutic ingredients are essential for the restoration or optimization of limb control in children with CP will grow.
PEDIATRIC ROBOT-ASSISTED THERAPY: POTENTIAL BENEFITS AND FUTURE CHALLENGES
Preliminary studies on the use of robot-assisted therapies for children with movement disorders due to CP or acquired brain injury have yielded promising results. Despite small sample sizes and variability in outcome measures, significant gains have been found on clinical measures of upper limb motor function and walking abilities. These early studies demonstrated the feasibility of robot-assisted therapies for children with CP or acquired brain injury and have begun to gather evidence about important treatment variables. Several benefits and expanded uses of this technology are highlighted below.
USING ROBOT MEASURES TO STUDY TREATMENT EFFECTS
Robot-derived measures are being used to examine important questions regarding treatment dose, intensity, and motor outcomes. For example, rehabilitation robots can easily quantify treatment dose by tracking the number of repetitions or time engaged in therapy. Because of these measures, a dose-dependent correlation was found between the distance and time walked during Lokomat training 15 and gains recorded in the GMFM dimension on walking abilities. Moreover, comparisons across upper limb studies 9, 12 suggest that the magnitude of change on the FMA was greater in children who received more intensive therapy (i.e., more movement repetitions) while continuing conventional therapies during the study period.
Another dose-related variable of interest is the degree to which active vs. passive participation in movement therapy is essential for improved motor learning. This question has been challenging to answer because Bactive[ participation during repetitive, task-specific practice has been difficult to quantify.
Although the forces exerted on the robot manipulandum are used to modify the amount of assistance provided during InMotion2 therapy, 32 these data are typically not used as a standard measurement of the child's active participation throughout the course of therapy. Similarly, the Lokomatdriven gait orthoses used in these early pediatric studies did not monitor active participation during training, 16 so the degree of gait initiation and effort exerted by study participants is not clear. Future studies can use robot-derived kinetic and kinematic measures more effectively to study this important research question. These quantitative data are particularly important when attentional variables are manipulated (e.g., random vs. sequential practice of reaching; use of cartoons or videos to motivate longer time in training; use of virtual tasks), and can inform theories of motor learning and recovery.
Robot-derived kinematic measures have been used to assess treatment effects on quality of movement in adults 13, 33 and children diagnosed with stroke or CP. 11, 12, 34 These analyses provide a means to examine how motor control variables such as speed and accuracy, smoothness of reach (jerk), interjoint coordination, or muscle tone/spasticity change in response to intervention. These tools have great potential to study whether/how patterns of skill acquisition differ when therapy is focused on the learning of new motor skills vs. the rehabilitation of lost functions. When applied to a specific diagnosis across age groups (such as pediatric vs. adult stroke), how motor learning is similar to or different from motor recovery can also be examined. As seen from the research described in this review, the preciseness and replicability of these kinematic measures provide insights into the effects of training on neuromotor pathways and allow us to examine the degree to which task characteristics, context, and behavioral demands (e.g., motivation, skill acquisition) impact motor performance.
RELATING TREATMENT OUTCOMES TO BASELINE ABILITIES
Variability in participant abilities at baseline contributes to challenges in identifying the most appropriate interventions and predicting treatment outcomes. The case series of Patritti et al. 14 systematically studied the effects of robot-assisted gait training with and without augmented feedback in four children with clearly different lower limb motor impairments at study onset. This work indicated that the child's baseline performance on the GMFM may be correlated with the development of different gait characteristics. Lower functioning children had greater improvements in standing (GMFM dimension D), whereas less involved children improved more in walking functions (GMFM dimension E) and endurance. Developmentally, stability precedes mobility, so it is essential to address both of these outcomes after robot-assisted gait training. Future studies could examine whether longer duration therapy (e.g., 93-wk trial) improves functional gait patterns and endurance in more involved children and whether gains in standing are precursors for functional walking abilities.
Even though the contribution of sensory processing to functional motor performance has been well established, impairments in tactile awareness and proprioception have been largely ignored in motor control research. There is much to learn regarding the impact of different forms of performance feedback on impaired sensorimotor processing in children with CP or acquired brain injury. Rehabilitation robots provide consistent haptic, visual, and auditory feedback that may facilitate improved sensory awareness and processing in addition to motor learning and recovery. Explicit feedback during robot-assisted therapies can increase the child's knowledge of movement attempts (internal focus on sensorimotor processing) and the effects of motor actions on treatment tasks (external focus on task objects or outcomes). By manipulating the type of feedback provided, knowledge will be gained regarding how to best facilitate gains in sensorimotor processing, test motor learning paradigms, and better customize treatment to a child's individual needs can be learned.
USING ROBOTS TO STUDY TASK-ORIENTED TRAINING
As robot-assisted technologies are used to explore and extend the effectiveness of rehabilitation interventions, further delineation and integration of task-oriented training will continue in an attempt to better align rehabilitation technologies with current therapy practice models. The relationship between the ecologic validity or relevance of treatment tasks to improved performance and participation in valued life roles and activities will be better addressed. Advances in robot-assisted therapies and VR systems will provide answers to important questions concerning attentional demands and the characteristics of training tasks and environments. For example, it is not known know how closely motor tasks and virtual task environments need to align with real-life functions (e.g., grasping and pouring, overground walking) to optimize treatment effects. Improved knowledge of key active ingredients based on the child's level of function is expected to optimize motor learning and generalization of acquired skills to functional daily needs. Translation of this knowledge to clinical practice has great potential to guide the selection of efficient and cost-effective therapy interventions and improve functional abilities of children and adults with neuromotor impairments.
CLINICAL ACCEPTANCE AND VALUE
Acceptance of robot-assisted therapy by rehabilitation clinicians, patients, and families requires evidence from large well-designed randomized control trials. Use of consistent outcome measures will allow for better between-study comparisons and greatly improve the understanding of key treatment effects. Preliminary studies, such as those described above, have laid the groundwork for clinically relevant, theory-driven studies that relate changes in body functions to greater activity level performance and participation. Caregivers of children with neurologically based motor impairments are concerned with variables such as treatment effectiveness, cost, ease of use, and accessibility for home use. Children will likely be more engaged in robot-assisted therapies that are fun and interactive and that provide opportunities for social interaction, competition, and reward for improved performance.
As we move forward with pediatric studies on the effects of robot-assisted therapy on upper and lower limb motor control and function, what has been learned from adult research can be applied to help guide research questions. The potential of rehabilitation technologies to improve clinical practice and outcomes for children with CP and acquired brain injury is great. As a whole, studies of robot-assisted therapy have come a long way over the past 15 yrs. Continued research will further explore its ability to offer effective, evidence-based treatment that is tailored to the individual's specific needs and desired outcomes.
